Atlanta, Georgia — The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) is set to convene for a crucial two-day meeting at CDC headquarters in Atlanta, Georgia, on Wednesday and Thursday, June 25-26, 2025. This gathering marks the first formal meeting of the committee since a significant overhaul of its membership was announced earlier this month by Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr.
ACIP serves as a vital independent panel comprising distinguished medical and public health experts. Its primary function is to provide essential advice and recommendations to the Director of the CDC regarding the safe, effective, and necessary clinical use of vaccines for the U.S. population. These recommendations play a foundational role in shaping federal vaccination guidelines and public health strategies nationwide.
Leadership Change and Stated Objectives
The upcoming meeting follows directly on the heels of a dramatic leadership change initiated by Secretary Kennedy. In an announcement made on June 9, 2025, Secretary Kennedy stated he was undertaking a “clean sweep” of ACIP’s existing membership. According to the Secretary, the stated purpose of this action was to “reestablish public confidence in vaccine science.”
As part of this sweeping change, the CDC removed all 17 existing members of the ACIP committee. Simultaneously, eight new members were appointed to the panel. The composition of the new committee and the expertise they bring to the table are expected to be closely scrutinized, particularly in light of the Secretary’s expressed motivations for the membership change.
Implications for Vaccine Policy
The recommendations issued by ACIP have far-reaching implications, influencing everything from routine childhood immunization schedules to guidelines for emergency vaccine deployment. The expertise and perspectives of the committee members are critical in evaluating complex data on vaccine safety, effectiveness, and the epidemiology of vaccine-preventable diseases.
With a significantly altered membership, observers and public health professionals will be keenly watching the June 25-26 meeting to understand how the new panel approaches its responsibilities and whether its deliberations signal any potential shifts in future vaccine guidance. The specific topics covered in the meeting will likely provide initial insights into the priorities and focus areas of the newly constituted committee.
Meeting Access and Agenda
The CDC has facilitated public access to the proceedings of the ACIP meeting. Interested individuals can observe the discussions via a live webcast, ensuring transparency for the public and stakeholders. Media representatives seeking to cover the meeting in person at the Atlanta headquarters were required to request credentials by a deadline of June 24, underscoring the importance of this event.
A draft agenda outlining the topics scheduled for discussion during the June 25-26 meeting is available on the official ACIP website. Reviewing this agenda will offer a preliminary understanding of the scientific presentations, data reviews, and potential votes that the committee may undertake during its session.
Looking Ahead
The meeting represents a pivotal moment for the CDC and the future direction of vaccine recommendations in the United States. As the newly appointed members begin their tenure, their work will be essential in maintaining the rigorous scientific standards necessary to inform public health policy and immunization practices. The outcomes of the June 25-26 meeting are anticipated to set the stage for ACIP’s activities in the coming months and years, under the new leadership structure implemented following Secretary Kennedy’s recent action.
